705 related articles for article (PubMed ID: 23286904)
21. [Risk control of traditional Chinese medicines containing aristolochis acids (AAs) based on influencing factors of content of AAs].
Tian JZ; Liang AH; Liu J; Zhang BL
Zhongguo Zhong Yao Za Zhi; 2017 Dec; 42(24):4679-4686. PubMed ID: 29493131
[TBL] [Abstract][Full Text] [Related]
22. Diabetes mellitus and its management with medicinal plants: A perspective based on Iranian research.
Rezaei A; Farzadfard A; Amirahmadi A; Alemi M; Khademi M
J Ethnopharmacol; 2015 Dec; 175():567-616. PubMed ID: 26283471
[TBL] [Abstract][Full Text] [Related]
23. Herbal medicines for the prevention of alcoholic liver disease: a review.
Ding RB; Tian K; Huang LL; He CW; Jiang Y; Wang YT; Wan JB
J Ethnopharmacol; 2012 Dec; 144(3):457-65. PubMed ID: 23058988
[TBL] [Abstract][Full Text] [Related]
24. Herbal medicines: challenges in the modern world. Part 3. China and Japan.
Teng L; Zu Q; Li G; Yu T; Job KM; Yang X; Di L; Sherwin CM; Enioutina EY
Expert Rev Clin Pharmacol; 2016 Sep; 9(9):1225-33. PubMed ID: 27232545
[TBL] [Abstract][Full Text] [Related]
25. Authentication is fundamental for standardization of Chinese medicines.
Zhao Z; Hu Y; Liang Z; Yuen JP; Jiang Z; Leung KS
Planta Med; 2006 Aug; 72(10):865-74. PubMed ID: 16902852
[TBL] [Abstract][Full Text] [Related]
26. The classification and application of toxic Chinese materia medica.
Liu X; Wang Q; Song G; Zhang G; Ye Z; Williamson EM
Phytother Res; 2014 Mar; 28(3):334-47. PubMed ID: 23722570
[TBL] [Abstract][Full Text] [Related]
27. Traditional Chinese medicine herbal preparations in restless legs syndrome (RLS) treatment: a review and probable first description of RLS in 1529.
Yan X; Wang WD; Walters AS; Wang Q; Liu YJ; Chu FY
Sleep Med Rev; 2012 Dec; 16(6):509-18. PubMed ID: 22459934
[TBL] [Abstract][Full Text] [Related]
28. [Create mathematical model and analysis of correlation between Chinese medicinal characteristics and immunoregulatory activity based on literature informatics].
Li YJ; Liu H; Wang HF; Guo YQ
Zhongguo Zhong Yao Za Zhi; 2007 Sep; 32(17):1783-6. PubMed ID: 17993002
[TBL] [Abstract][Full Text] [Related]
29. Omics and its potential impact on R&D and regulation of complex herbal products.
Pelkonen O; Pasanen M; Lindon JC; Chan K; Zhao L; Deal G; Xu Q; Fan TP
J Ethnopharmacol; 2012 Apr; 140(3):587-93. PubMed ID: 22313626
[TBL] [Abstract][Full Text] [Related]
30. [Study on reference extracts for quality assessment on traditional Chinese medicines based on akebiae saponin].
Yuan X; Gao H; Wang Z; Zhang Q
Zhongguo Zhong Yao Za Zhi; 2012 Aug; 37(16):2413-6. PubMed ID: 23234140
[TBL] [Abstract][Full Text] [Related]
31. Potential genotoxicity of traditional chinese medicinal plants and phytochemicals: an overview.
Zhou J; Ouedraogo M; Qu F; Duez P
Phytother Res; 2013 Dec; 27(12):1745-55. PubMed ID: 23420770
[TBL] [Abstract][Full Text] [Related]
32. Molecular network and chemical fragment-based characteristics of medicinal herbs with cold and hot properties from Chinese medicine.
Liang F; Li L; Wang M; Niu X; Zhan J; He X; Yu C; Jiang M; Lu A
J Ethnopharmacol; 2013 Jul; 148(3):770-9. PubMed ID: 23702041
[TBL] [Abstract][Full Text] [Related]
33. Toxicogenomics for the prediction of toxicity related to herbs from traditional Chinese medicine.
Youns M; Hoheisel JD; Efferth T
Planta Med; 2010 Dec; 76(17):2019-25. PubMed ID: 20957595
[TBL] [Abstract][Full Text] [Related]
34. Molecular identification and cytotoxicity study of herbal medicinal materials that are confused by Aristolochia herbs.
Li M; Au KY; Lam H; Cheng L; But PP; Shaw PC
Food Chem; 2014 Mar; 147():332-9. PubMed ID: 24206727
[TBL] [Abstract][Full Text] [Related]
35. [Current research situation of nephrotoxicity of Chinese herbal medicine].
Feng X; Fang SN; Gao YX; Liu JP; Chen W
Zhongguo Zhong Yao Za Zhi; 2018 Feb; 43(3):417-424. PubMed ID: 29600603
[TBL] [Abstract][Full Text] [Related]
36. [Dao-di herbs and its change of cultivated origin place].
Meng X; Chen S; Wang X
Zhongguo Zhong Yao Za Zhi; 2011 Jul; 36(13):1687-92. PubMed ID: 22032126
[TBL] [Abstract][Full Text] [Related]
37. Systems approaches and polypharmacology for drug discovery from herbal medicines: an example using licorice.
Liu H; Wang J; Zhou W; Wang Y; Yang L
J Ethnopharmacol; 2013 Apr; 146(3):773-93. PubMed ID: 23415946
[TBL] [Abstract][Full Text] [Related]
38. Bioactivation of herbal constituents: simple alerts in the complex system.
Fang ZZ; Zhang YY; Wang XL; Cao YF; Huo H; Yang L
Expert Opin Drug Metab Toxicol; 2011 Aug; 7(8):989-1007. PubMed ID: 21609190
[TBL] [Abstract][Full Text] [Related]
39. Chinese proprietary medicine in Singapore: regulatory control of toxic heavy metals and undeclared drugs.
Koh HL; Woo SO
Drug Saf; 2000 Nov; 23(5):351-62. PubMed ID: 11085343
[TBL] [Abstract][Full Text] [Related]
40. Regulation of herbal medicines in Brazil.
Carvalho AC; Ramalho LS; Marques RF; Perfeito JP
J Ethnopharmacol; 2014 Dec; 158 Pt B():503-6. PubMed ID: 25169216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
